Please use a Javascript enable browser to see page contents.

RCB1892  :  SKG-IIIa
Comment Cervical carcinoma cell line derived from human. TA-4, CA-4, TPA, placental ALP are positive. Regan isoenzyme producing. p53 normal, p51 mutation (+), HLA-A 2402/. TKG0462 (Deposited from Tohoku Univ.).
Animal human
Sex Female
Tissue cervix
Morphology epithelial-like
Anchoraged Yes
Medium HamF12+10%FBS
Antibiotics Free
Growth temp 37oC
CO2 concentration 5%
Passage method 0.25% trypsin
Split ratio 1:8 split
Subculture frequency twice/week
Cloned No
Lifespan infinite
Mycoplasma -
Isozyme analysis LD, NP
Chr distrb 41-83(50):/41(1),42(3),43(24),44(11),45(9),81(1)/
Short Tandem Repeat OK
Originator Nozawa, S.
Depositor Obinata, Masuo
Restriction Basically, there is no restriction regarding academic use. a
Reference 2852 2853 2854
Photo 2006-06-02
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, Category I and II, depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In case of Restriction "a" or "f", please contact RIKEN BRC( regarding any kind of for-profit use.

back back
RIKEN BioResource Center